Vanguard Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Vanguard Capital Management's ALT Position: Q3 2026 in Review
Vanguard Capital Management reduced its Altimmune (ALT) stake by 4.5% in Q3 2026, selling an estimated $1.12M and leaving 7,812,919 shares worth $22.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2336.
Vanguard Capital Management first reported a position in ALT in Q1 2026 and has held it in 3 quarters since. The position peaked at $24.9M in Q2 2026. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- Vanguard Capital Management held 7,812,919 shares of Altimmune worth $22.3M as of Q3 2026.
- Vanguard Capital Management sold 364,833 Altimmune shares in Q3 2026, an estimated $1.12M.
- Altimmune made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2336 holding.
- Vanguard Capital Management first reported a position in Altimmune in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Altimmune position peaked at $24.9M in Q2 2026.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.